United States Biotechnology & Medical Research

ENDRA Life Sciences Inc (NDRA)

Track

ENDRA Life Sciences Inc. recorded one notable insider trading activity recently, involving a proposed sale of 70,822 shares valued at $425,000 by board member Anthony DiGiandomenico on June 26, 2026. This transaction occurs amidst a 20.8% decline in stock price over the past quarter and following a significant miss in the latest earnings report.

No active insider signal

Not featured in screeners

Featured in screeners

No active insider signal

Not featured in screeners

Ticker: NDRA Exchange: NAS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

Activity signals detected for ENDRA Life Sciences Inc

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ENDRA Life Sciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Proposed sale 26 Jun 2026

Value US$597,456.24 | Price 331.17 | Shares 22,641

Buy 27 Aug 2024

Value US$3,080,243.67 | Price 347.78 | Shares 17,270 (-40.0%)

Buy 18 May 2023

Value US$24,750.00 | Price 1.65 | Shares 15,000 (+78.4%)

Buy 2 May 2023

Value US$99,999.60 | Price 1.20 | Shares 83,333 (+436.3%)

Buy 9 Dec 2022

Value US$5,100.00 | Price 3.40 | Shares 1,500 (+8.5%)

Buy 23 Nov 2022

Value US$1,700.00 | Price 0.17 | Shares 10,000 (+6.5%)

Buy 22 Aug 2022

Value US$5,200.00 | Price 0.26 | Shares 20,000 (+15.1%)

Buy 22 Aug 2022

Value US$5,400.00 | Price 0.27 | Shares 20,000 (+6.0%)

Buy 26 May 2022

Value US$5,250.00 | Price 0.21 | Shares 25,000 (+8.1%)

Buy 18 May 2022

Value US$5,500.00 | Price 0.22 | Shares 25,000 (+8.8%)

Buy 17 May 2022

Value US$969.00 | Price 0.19 | Shares 5,100 (+5.5%)

Buy 16 May 2022

Value US$19,630.00 | Price 0.20 | Shares 100,000 (+304.3%)

Planned sale 7 Apr 2021

Value US$37,950.00 | Price 2.53 | Shares 15,000 (-5.5%)

Planned sale 29 Mar 2021

Value US$44,437.50 | Price 2.37 | Shares 18,750 (-6.4%)

Planned sale 13 Jan 2021

Value US$15,065.60 | Price 1.10 | Shares 13,696 (-89.7%)

Planned sale 12 Jan 2021

Value US$6,619.20 | Price 1.05 | Shares 6,304 (-29.2%)

Planned sale 8 Jan 2021

Value US$9,000.00 | Price 0.90 | Shares 10,000 (-23.3%)

Planned sale 8 Jan 2021

Value US$8,207.14 | Price 0.94 | Shares 8,731 (-28.8%)

Planned sale 6 Jan 2021

Value US$31,410.00 | Price 0.90 | Shares 34,900 (-30.4%)

Planned sale 6 Jan 2021

Value US$10,592.86 | Price 0.94 | Shares 11,269 (-27.1%)

Planned sale 5 Jan 2021

Value US$90.00 | Price 0.90 | Shares 100 (-0.1%)

Planned sale 17 Dec 2020

Value US$18,250.00 | Price 0.73 | Shares 25,000 (-37.5%)

Planned sale 4 Dec 2020

Value US$59,360.77 | Price 0.83 | Shares 71,519 (-43.7%)

Planned sale 13 Nov 2020

Value US$8,100.00 | Price 0.81 | Shares 10,000 (-13.1%)

Planned sale 1 Oct 2020

Value US$7,200.00 | Price 0.72 | Shares 10,000 (-11.6%)

Buy 8 Jun 2020

Value US$4,600.00 | Price 0.92 | Shares 5,000 (+1.8%)

Buy 29 May 2020

Value US$9,000.00 | Price 0.90 | Shares 10,000 (+11.2%)

Buy 28 May 2020

Value US$9,100.00 | Price 0.91 | Shares 10,000 (+12.6%)

Buy 28 May 2020

Value US$4,500.00 | Price 0.90 | Shares 5,000 (+1.8%)

Buy 27 May 2020

Value US$8,500.00 | Price 0.85 | Shares 10,000 (+14.5%)

Buy 26 May 2020

Value US$8,200.00 | Price 0.82 | Shares 10,000 (+16.9%)

Buy 22 May 2020

Value US$7,800.00 | Price 0.78 | Shares 10,000 (+4.1%)

Buy 21 May 2020

Value US$7,100.00 | Price 0.71 | Shares 10,000 (+20.4%)

Buy 27 Sep 2019

Value US$11,800.00 | Price 1.18 | Shares 10,000 (+100.0%)

Buy 23 Aug 2019

Value US$7,750.00 | Price 1.55 | Shares 5,000 (+100.0%)

Buy 22 Aug 2019

Value US$7,800.00 | Price 1.56 | Shares 5,000 (+inf%)

Buy 10 Jun 2019

Value US$570.00 | Price 1.14 | Shares 500 (+5.3%)

Buy 7 Jun 2019

Value US$3,136.00 | Price 1.12 | Shares 2,800 (+41.8%)

Buy 6 Jun 2019

Value US$7,326.00 | Price 1.11 | Shares 6,600 (+6600.0%)

Buy 5 Jun 2019

Value US$120.00 | Price 1.20 | Shares 100 (+inf%)

Buy 16 May 2019

Value US$33,900.00 | Price 1.13 | Shares 30,000 (+33.4%)

Sale 24 Oct 2018

Value US$125,283.00 | Price 4.18 | Shares 30,000 (-9.1%)

Sale 23 Oct 2018

Value US$210,885.00 | Price 4.22 | Shares 50,000 (-13.2%)

Sale 22 Oct 2018

Value US$209,077.98 | Price 4.16 | Shares 50,200 (-11.7%)

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-25	2026-06-26	PrS Proposed sale	3.4 Anthony DiGiandomenico Board Member	22,641 331.17 US$597,456	22,641	331.17	US$597,456
2024-08-29	2024-08-27	B Purchase	2.0 UBS Group AG Large shareholder	17,270 -40.0% 347.78 US$3,080,244	17,270 -40.0%	347.78	US$3,080,244
2023-05-22	2023-05-18	B Purchase	1.3 Thornton Michael Milos Chief Technology Officer Officer	30,960 -24.7% 302.33 US$244,651	30,960 -24.7%	302.33	US$244,651
2023-05-03	2023-05-02	B Purchase	3.4 DIGIANDOMENICO ANTHONY Non-Executive Director	83,333 +436.3% 1.20 US$100,000	83,333 +436.3%	1.20	US$100,000
2022-12-13	2022-12-09	B Purchase	1.3 Thornton Michael Milos Chief Technology Officer Officer	1,500 +8.5% 3.40 US$5,100	1,500 +8.5%	3.40	US$5,100
2022-11-28	2022-11-23	B Purchase	1.4 Tokman Alexander Y Non-Executive Director	10,000 +6.5% 0.17 US$1,700	10,000 +6.5%	0.17	US$1,700
2022-08-24	2022-08-22	B Purchase	1.4 Tokman Alexander Y Non-Executive Director	20,000 +15.1% 0.26 US$5,200	20,000 +15.1%	0.26	US$5,200
2022-08-24	2022-08-22	B Purchase	1.3 Thornton Michael Milos Chief Technology Officer Officer	20,000 +6.0% 0.27 US$5,400	20,000 +6.0%	0.27	US$5,400
2022-05-31	2022-05-26	B Purchase	1.3 Thornton Michael Milos Chief Technology Officer Officer	25,000 +8.1% 0.21 US$5,250	25,000 +8.1%	0.21	US$5,250
2022-05-23	2022-05-18	B Purchase	1.3 Thornton Michael Milos Chief Technology Officer Officer	25,000 +8.8% 0.22 US$5,500	25,000 +8.8%	0.22	US$5,500
2022-05-19	2022-05-17	B Purchase	0.5 Michelon Francois Roger Chief Executive Officer Executive Director	5,100 +5.5% 0.19 US$969	5,100 +5.5%	0.19	US$969
2022-05-17	2022-05-16	B Purchase	1.4 Tokman Alexander Y Non-Executive Director	100,000 +304.3% 0.20 US$19,630	100,000 +304.3%	0.20	US$19,630
2021-04-07	2021-04-07	PlS Planned sale	1.3 Thornton Michael Milos Chief Technology Officer Officer	15,000 -5.5% 2.53 US$37,950	15,000 -5.5%	2.53	US$37,950
2021-04-07	2021-03-29	PlS Planned sale	1.3 Thornton Michael Milos Chief Technology Officer Officer	18,750 -6.4% 2.37 US$44,438	18,750 -6.4%	2.37	US$44,438
2021-01-14	2021-01-13	PlS Planned sale	Maloberti Renaud Bertrand Chief Commercial Officer Officer	13,696 -89.7% 1.10 US$15,066	13,696 -89.7%	1.10	US$15,066
2021-01-14	2021-01-12	PlS Planned sale	Maloberti Renaud Bertrand Chief Commercial Officer Officer	6,304 -29.2% 1.05 US$6,619	6,304 -29.2%	1.05	US$6,619
2021-01-08	2021-01-08	PlS Planned sale	1.4 Tokman Alexander Y Non-Executive Director	10,000 -23.3% 0.90 US$9,000	10,000 -23.3%	0.90	US$9,000
2021-01-08	2021-01-08	PlS Planned sale	Maloberti Renaud Bertrand Chief Commercial Officer Officer	8,731 -28.8% 0.94 US$8,207	8,731 -28.8%	0.94	US$8,207
2021-01-06	2021-01-06	PlS Planned sale	0.5 Wells David R. Chief Financial Officer Officer	34,900 -30.4% 0.90 US$31,410	34,900 -30.4%	0.90	US$31,410
2021-01-06	2021-01-06	PlS Planned sale	Maloberti Renaud Bertrand Chief Commercial Officer Officer	11,269 -27.1% 0.94 US$10,593	11,269 -27.1%	0.94	US$10,593
2021-01-06	2021-01-05	PlS Planned sale	0.5 Wells David R. Chief Financial Officer Officer	100 -0.1% 0.90 US$90	100 -0.1%	0.90	US$90
2020-12-21	2020-12-17	PlS Planned sale	Maloberti Renaud Bertrand Chief Commercial Officer Officer	25,000 -37.5% 0.73 US$18,250	25,000 -37.5%	0.73	US$18,250
2020-12-08	2020-12-04	PlS Planned sale	0.5 Michelon Francois Roger Chief Executive Officer Executive Director	71,519 -43.7% 0.83 US$59,361	71,519 -43.7%	0.83	US$59,361
2020-11-16	2020-11-13	PlS Planned sale	Maloberti Renaud Bertrand Chief Commercial Officer Officer	10,000 -13.1% 0.81 US$8,100	10,000 -13.1%	0.81	US$8,100
2020-10-05	2020-10-01	PlS Planned sale	Maloberti Renaud Bertrand Chief Commercial Officer Officer	10,000 -11.6% 0.72 US$7,200	10,000 -11.6%	0.72	US$7,200
2020-06-09	2020-06-08	B Purchase	3.4 DIGIANDOMENICO ANTHONY Non-Executive Director	5,000 +1.8% 0.92 US$4,600	5,000 +1.8%	0.92	US$4,600
2020-06-01	2020-05-29	B Purchase	0.9 Basenese Lou Non-Executive Director	10,000 +11.2% 0.90 US$9,000	10,000 +11.2%	0.90	US$9,000
2020-05-29	2020-05-28	B Purchase	0.9 Basenese Lou Non-Executive Director	10,000 +12.6% 0.91 US$9,100	10,000 +12.6%	0.91	US$9,100
2020-05-29	2020-05-28	B Purchase	3.4 DIGIANDOMENICO ANTHONY Non-Executive Director	5,000 +1.8% 0.90 US$4,500	5,000 +1.8%	0.90	US$4,500
2020-05-28	2020-05-27	B Purchase	0.9 Basenese Lou Non-Executive Director	10,000 +14.5% 0.85 US$8,500	10,000 +14.5%	0.85	US$8,500
2020-05-27	2020-05-26	B Purchase	0.9 Basenese Lou Non-Executive Director	10,000 +16.9% 0.82 US$8,200	10,000 +16.9%	0.82	US$8,200
2020-05-26	2020-05-22	B Purchase	3.4 DIGIANDOMENICO ANTHONY Non-Executive Director	10,000 +4.1% 0.78 US$7,800	10,000 +4.1%	0.78	US$7,800
2020-05-22	2020-05-21	B Purchase	0.9 Basenese Lou Non-Executive Director	10,000 +20.4% 0.71 US$7,100	10,000 +20.4%	0.71	US$7,100
2019-09-30	2019-09-27	B Purchase	0.5 Wells David R. Chief Financial Officer	10,000 +100.0% 1.18 US$11,800	10,000 +100.0%	1.18	US$11,800
2019-08-26	2019-08-23	B Purchase	Wells David R. Chief Financial Officer Officer	5,000 +100.0% 1.55 US$7,750	5,000 +100.0%	1.55	US$7,750
2019-08-26	2019-08-22	B Purchase	Wells David R. Chief Financial Officer Officer	5,000 +inf% 1.56 US$7,800	5,000 +inf%	1.56	US$7,800
2019-06-14	2019-06-10	B Purchase	0.9 Harsh Michael	500 +5.3% 1.14 US$570	500 +5.3%	1.14	US$570
2019-06-10	2019-06-07	B Purchase	0.9 Harsh Michael	2,800 +41.8% 1.12 US$3,136	2,800 +41.8%	1.12	US$3,136
2019-06-10	2019-06-06	B Purchase	0.9 Harsh Michael	6,600 +6600.0% 1.11 US$7,326	6,600 +6600.0%	1.11	US$7,326
2019-06-10	2019-06-05	B Purchase	0.9 Harsh Michael	100 +inf% 1.20 US$120	100 +inf%	1.20	US$120
2019-05-20	2019-05-16	B Purchase	1.3 Thornton Michael Milos Chief Technology Officer	30,000 +33.4% 1.13 US$33,900	30,000 +33.4%	1.13	US$33,900
2018-10-24	2018-10-24	S Sale	Longboard Capital Advisors, LLC Large shareholder	30,000 -9.1% 4.18 US$125,283	30,000 -9.1%	4.18	US$125,283
2018-10-24	2018-10-23	S Sale	Longboard Capital Advisors, LLC Large shareholder	50,000 -13.2% 4.22 US$210,885	50,000 -13.2%	4.22	US$210,885
2018-10-24	2018-10-22	S Sale	Longboard Capital Advisors, LLC Large shareholder	50,200 -11.7% 4.16 US$209,078	50,200 -11.7%	4.16	US$209,078

Explore more

More insider trading research around ENDRA Life Sciences Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Biotechnology & Medical Research companies with insider activity

Insider trading in North America

ENDRA Life Sciences Inc (NDRA)

Track

Featured in screeners

Upgrade for signal details

Transactions

Insider

Sort by

Trades

Explore more